Illumina said this week that it has appointed Richard Klausner as senior vice president and chief medical officer.
Prior to joining Illumina, Klausner was managing partner of venture capital firm The Column Group. He has also served as executive director for global health at the Bill and Melinda Gates Foundation, and as the eleventh director of the National Cancer Institute between 1995 and 2001. Klausner has also been chief of cell biology and metabolism at the National Institute of Child Health and Human Development; past president of the American Society of Clinical Investigation; and chairman of the National Science Education Standards Projects of the National Academy of Sciences. He holds an MD from Duke University.
Gregory Lucier has been appointed to the board of directors at RainTree Oncology and elected chairman of the board at Sanford-Burnham Medical Research Institute.
Lucier is CEO and chairman of Life Technologies. He also serves on the boards of CareFusion, Synthetic Genomics, and Rady Children's Hospital. He holds a BS in engineering from Pennsylvania State University and an MBA from Harvard Business School.